Plunkett Research Online: Novo-Nordisk AS

NOVO-NORDISK AS (NVO:NYS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Novo Nordisk AS is a global healthcare company engaged in the discovery, development, manufacturing and marketing pharmaceutical products. As a leader in diabetes care, it has one of the broadest diabetes product portfolios in the industry, including new generation insulins, a full portfolio of mod.....



Novo-Nordisk AS
Ticker: NVO
Exchange: NYS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 45 44448888
Fax: 45 44490555
Address: Novo Alle
Bagsværd, 2880 Denmark

Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Diabetes
Hormone Replacement Therapy
Growth Hormone Drugs
Hemophilia Drugs
Insulin Delivery Systems
Educational & Training Services
ContactsDescription
Lars JorgensenCEO/President
Jesper BrandgaardCFO/Executive VP
See More
Novo Nordisk AS is a global healthcare company engaged in the discovery, development, manufacturing and marketing pharmaceutical products. As a leader in diabetes care, it has one of the broadest diabetes product portfolios in the industry, including new generation insulins, a full portfolio of mod.....See More See More

Auditor: PricewaterhouseCoopers
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Tresiba
Xultophy
Victoza
Ryzodeg
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: